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Solobacterium moorei is a strict anaerobic gram-positive rod. It is found in the human microbiota in
different parts of the body, but it also appears to be an opportunistic pathogen in some infectious
processes. We describe six cases of severe infections identified in 2016 in which S. moorei was isolated
alone or in mixed culture involving other anaerobes or both aerobic and anaerobic bacteria. Three cases
were associated with the oral cavity, including a middle ear infection, a wound infection after total
laryngectomy, and a mandibular abscess as a result of bisphosphonate therapy. In the other three pa-
tients, the sites of infection had no connections with the oral cavity and included chronic osteomyelitis of
the tibia, a superinfection of cutaneous tuberculosis associated with hidradenitis suppurativa, and the
isolation of S. moorei from the blood culture of a cachectic man with several comorbidities. Based on our
findings, S. moorei does not appear to be that virulent of a bacterium; except for the case with bacter-
aemia, S. moorei was recovered as a co-pathogen in patients with several immunosuppressive predis-
posing factors. We highlight the finding that the routine use of MALDI-TOF MS in microbiology
laboratories can in a timely and detailed manner identify members of mixed infections involving
different anaerobic bacteria that may be rare and difficult-to-culture and identify species, such as
S. moorei.
© 2020 Elsevier Ltd. All rights reserved.1. Introduction
Solobacterium moorei is an infrequently isolated strict anaerobic
gram-positive rod that is approximately 0.2 0.4e0.7 mm in size. It
typically appears as a straight or slightly curved rod in pairs or in
short chains without any flagella. It is relatively inactive biochem-
ically, which makes it difficult to identify by classical methods.
S. moorei was first described by Kageyama and Benno in 2000 [1],
when it was isolated from human faeces and was considered a
member of the intestinal microbiome. This Eubacterium-like ba-
cillus was originally known as Bulleida extructa or Bulleida moorei. Itiology, University of Szeged,
.hu (K.P. Sarvari).differed from other gram-positive anaerobic genera such as Bifi-
dobacterium, Lactobacillus, and Propionibacterium, and according to
16S rRNA gene sequencing, it had only 86% sequence homology
with Erysipelothrix rhusiopathiae and 87% with Holdemania fili-
formis. Thus, this species was classified as a member of the new
genus Solobacterium [1]. Although S. moorei was first isolated from
human faeces, this bacterium is a constant member of the micro-
biota of the human oropharynx [2]. The involvement of S. moorei as
an opportunistic pathogen in different infections has been reported
in recent years. It is associated with different types of serious
underlining diseases or predisposing factors, such as cancers,
immunosuppressive status, intravenous drug abuse, septic pul-
monary embolism, and thrombosis [3e5]. S. moorei has also been
reported as a possible pathogen in oral infections, such as peri-
implantitis, periradicular lesions, or other endodontic infections
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S. moorei with halitosis as a causative agent [2]. In most reported
cases, S. mooreiwas isolated frommixed infections: three to eleven
different aerobic and anaerobic species have been cultured in
combination with S. moorei [4,5]. Few publications have described
S. moorei as a causative agent of bacteraemia when isolated as a
single pathogen or together with one or two other species [12,13].
Here we report six cases from 2016 in which S. moorei was
isolated alone or together with different aerobic and anaerobic
species from patients treated in various departments of the Uni-
versity Clinic, Szeged, Hungary. This study was approved by the
Ethics Committee of the University of Szeged, according to the
Declaration of Helsinki (1975) and its revision in 2002.
2. Materials and methods
Samples from the patients were transferred to the laboratory in
anaerobic transport vials, except for the septic patient, fromwhom
two sets of blood culture bottles (aerobic and anaerobic) were
submitted. The samples were processed by standard methods [14]
using anaerobic Schaedler blood agar (bioMerieux, Marcy l'Etoile,
France) for the isolation of anaerobes by incubating the plates at
37 C for 48e72 h in an anaerobic chamber (Perkin Elmer, Bea-
consfield, UK) (85% N2, 10% CO2, 5% H2). Simultaneously, the aerobic
bacteria were cultured on Columbia (with 5% sheep's blood),
chocolate, and eosin methylene blue agar plates (bioMerieux,
France), and the fungi were cultured on Sabouraud agar plates
(bioMerieux, France) at 35 C for 24 h. The identification was per-
formed with Matrix-Assisted Laser Desorption/Ionisation Time-of-
Flight Mass Spectrometry (MALDI-TOF MS, Bruker Daltonik, Ger-
many) using Biotyper Version 3.0 software. When the log (score)
value of the strains was2.000, we accepted it as a reliable species-
level identification result for all strains isolated from these patients.
All S. moorei strains were identified with a log (score) value of
>2.000 (between 2.04 and 2.288). The antibiotic susceptibility of
the aerobic bacteria was determined by the disc diffusion method
according to the EUCAST guidelines (http://www.eucast.org).
Antibiotic susceptibility to penicillin, amoxicillin/clavulanic acid,
clindamycin, imipenem, and metronidazole was assessed using the
E-test (bioMerieux, France) on the S. moorei isolates obtained from
the blood culture. For mixed infections involving anaerobic bacte-
ria, including S. moorei, antibiotic therapy was determined ac-
cording to known literature data [14,15].
3. Case reports
3.1. Case 1
A 58-year-old cachectic man with a previous medical record of
alcoholic polyneuropathy, encephalopathy, chronic obstructive
pulmonary disease, a broken left femoral neck, atherosclerosis, and
neuromuscular dysfunction of the urinary bladder was admitted to
the emergency department with dehydration, unproductive cough,
and pain in the left kidney area. Chest CT diagnosed a right central
lung carcinoma (38 48 72 mm) with hilar lymph node metas-
tases, and a histopathological examination identified it as an
anaplastic solid carcinoma. As sepsis developed (white blood cells:
29.40 G/l, C-reactive protein: 361.2mg/dl, body temperature:
36.0 C, blood pressure: 80e101/41e62mmHg, pulse: 92e98 beats/
min), blood cultures were taken. A pure culture of S. moorei was
isolated from one anaerobic bottle after 63 h of incubation. Anti-
biotic susceptibility testing was performed, and the minimum
inhibitory concentration (MIC) values were as follows: penicillin,
0.016 ml/ml; amoxicillin/clavulanic acid, 0.016 ml/ml; clindamycin,
0.016 ml/ml; imipenem, 0.002 ml/ml; metronidazole, 0.064 ml/ml.The patient's clinical status deteriorated, he refused any type of
therapy (including antibiotics), and he was transported to the
Department of Internal Medicine. After 18 h of observation, he died
of sepsis, accompanied by bronchiolitis, pulmonary oedema, and
abscess followed by pyothorax in the upper lobe of the right lung
(Table 1).
3.2. Case 2
Case 2 was a 71-year-old female patient with colorectal and
facial skin cancers in her past medical history who had broken her
right tibia twice, which had been treatedwith conservative therapy.
Although her wound from the previously broken tibia had secreted
serous fluid since 2010, she did not accept conventional health care;
instead, she used alternative medical treatment over the following
years. In 2016, her right legwas broken again, and shewas admitted
to the Department of Traumatology, where the injured tibia was
plastered. Chronic osteomyelitis and a finger-sized fistula in the
middle third of the tibia were diagnosed. Serous fluid from the
fistula was sent to the microbiological laboratory for culturing, and
large numbers of colonies of S. moorei, Actinomyces odontolyticus,
Actinomyces turicensis, Veillonella atypical, and Atopobium rimae
were isolated anaerobically. During the aerobic cultivation, a few
colonies of Staphylococcus aureus and Klebsiella oxytoca were also
isolated. The patient refused both operation for her right tibia and
antibiotic drug administration. After local disinfection with
povidone-iodine, she was dismissed from the Department of
Traumatology. The outcome of this infection is unknown (Table 1).
3.3. Case 3
A 49-year-old man with a previous medical record of diabetes
mellitus and hypertonia has been suffering from chronic hidrade-
nitis suppurativa in the axillary, inguinal, and gluteal regions since
2004. In 2008, on the posterior part of the limbs, painful verrucous
knots appeared, which were treated with antibiotics, but he did not
recover. After two years, a punch biopsy from the arms identified
tuberculosis verrucosa cutis, and his Mycobacterium tuberculosis
complex PCR was positive. He received long-term antituberculotic
therapy (isoniazid þ pyrazinamide þ ethambutol þ rifampicin)
until 2016, when his clinical status improved and the discharge
disappeared. The crusted skin of the gluteal regionwas operated on
many times. After recovery from the operations, signs of hidrade-
nitis suppurativa appeared on the left gluteal region. A pus sample
was taken and sent to the microbiological laboratory. S. moorei,
Anaerococcus vaginalis, Prevotella timonensis, Prevotella nigrescens,
Porphyromonas somerae, Anaerococcus hydrogenalis, and Strepto-
coccus constellatus were isolated. All these bacteria were present
with high colony counts in the sample. Due to this mixed infection,
the patient received clindamycin per os (2 300 mg per day)
therapy for one month. The patient recovered and has been
controlled regularly through the present day (Table 1).
3.4. Case 4
In September 2015, a 53-year-old man with a previous medical
history of chronic parodontopathy, hypertension, smoking, alcohol
abuse, and cachexia was admitted to the Department of Oral and
Maxillofacial Surgery. He suffered from mild swelling of the right
cheek and experienced pain caused by the pressure. He had lost
15 kg of weight over the previous two months. A right maxillary
sinus wall destructing cancer was found on a chest and neck CT, and
histopathological examination identified invasive basaloid squa-
mous cell carcinoma, stage III (T4N0M0). Two months later, a right
hemi-maxillectomy with cervical block dissection was performed.
Table 1
Microbiological results of the six cases where Solobacterium moorei was present alone or in mixed culture in the patient's sample.
Cases Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Sample type Blood culture Serous fluid from
tibia
Pus from gluteal
region
Pus from mandibula Pus from middle ear Wound of
laryngectomy
Isolated
species
Anaerobic Solobacterium
moorei
Solobacterium moorei Solobacterium moorei Solobacterium moorei Solobacterium
moorei
Solobacterium
moorei
Actinomyces
odontolyticus
Anaerococcus
hydrogenalis
Fusobacterium necrophorum Actinomyces
randingae
Lactobacillus orale
Actinomyces
turicensis
Anaerococcus
vaginalis
Fusobacterium
nucleatum
Atopobium rimae Prevotella nigrescens Prevotella buccae
Veillonella atypica Prevotella timonensis Prevotella
nanceiensis
Porphyromonas
somerae
Aerobic Klebsiella oxytoca Streptococcus
constellatus
Pseudomonas
aeruginosa
Staphylococcus
aureus
Staphylococcus
aureus
Therapy No antibiotic
therapy
No antibiotic therapy Clindamycin Metronidazole, Amoxicillin/
clavulanic acid
Ciprofloxacin Metronidazole
Clinical outcome Died No further data Recovered Recovered Recovered Recovered
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weekly scheduled chemotherapy (30mg/m2 cisplatin intrave-
nously) and radiotherapy (2.8  1.8 Gy þ 12  1.8 Gy). In February
2016, he complained of double vision, radiating pain in the right
ear, and hearing loss. Purulent inflammation of the right middle ear
was diagnosed. Puncture was performed, and from the gained pus,
S. moorei and Actinomyces randingae were isolated from the
enrichment broth. S. aureus and Pseudomonas aeruginosa were
isolated in large numbers of colonies after 24 h of aerobic incuba-
tion. Because both aerobic strains were fully susceptible to cipro-
floxacin, the patient received i.v. ciprofloxacin therapy (2 400mg
daily) for five days. He did not receive any anti-anaerobic drugs
because S. moorei and A. randingae were considered contaminants,
and the patient finally recovered (Table 1).Fig. 1. S. moorei colonies of the subculture on Schaedler anaerobic blood agar after 48
hours of incubation in anaerobic chamber.3.5. Case 5
A 63-year-old man had been suffering frommitral insufficiency,
ischaemic heart disease, and recurrent metastatic urinary bladder
cancer since 2008. He received palliative chemotherapy (Tegafur)
for bone metastasis between September and November 2005
(which was stopped due to gastric complaints), and bisphospho-
nate (sodium clodronate) therapy was administered between 2008
and 2011. Presumably due to the side effects of the bisphosphonate
therapy, the patient lost all his teeth. In 2011, due to osteonecrosis,
his mandible had to be resected marginally, and a sequestrectomy
was performed. In 2016, hewas admitted to the Department of Oral
and Maxillofacial Surgery with a submandibular abscess because of
suspected medication-related osteonecrosis of the jaw as a result of
the bisphosphonate therapy. The panoramic X-ray showed osteo-
penia between the lower premolar regions. The CT scan revealed a
definitive abscess in the left mandibular region and also raised the
suspicion of chronic osteomyelitis. The abscess ruptured sponta-
neously, and pus was sent in anaerobic transport media to the
microbiological laboratory. S. moorei and Fusobacterium necropho-
rumwere isolated with high colony counts. The patient received i.v.
amoxicillin/clavulanic acid (3 1.2 g daily for five days) and
metronidazole (2 500 mg daily for five days). Irrigation with
povidone-iodine and hydrogen peroxide was recommended when
he was discharged. After a five-day-long stay at the Department of
Oral and Maxillofacial Surgery, he was transferred to the Depart-
ment of Oncotherapy, and amoxicillin/clavulanic acid wasadministered for seven more days per os. He recovered from the
infection (Table 1).
3.6. Case 6
A 43-year-old man with a previous medical history of heavy
smoking and alcohol abusewas admitted to the Department of Oto-
Rhino-Laryngology and Head-Neck Surgery with stage II laryngeal
squamous cell carcinoma. Despite undergoing radiotherapy, hem-
ilaryngectomy, urgent tracheostomy, and finally, total laryngec-
tomy were performed because of the cancer progression. A sample
from the surgical wound during the total laryngectomy was sent to
the microbiological laboratory, and S. moorei, Fusobacterium
nucleatum, Prevotella nanceiensis, Lactobacillus orale, and Prevotella
buccaewere isolated in large numbers under anaerobic conditions.
The patient received i.v. metronidazole (2 500 mg daily) therapy
for seven days. No further infectious process was observed in this
patient after the laryngectomy (Table 1).
4. Discussion
After the introduction of MALDI-TOF MS for the routine
Table 2
Overview of earlier published case reports of infections when S. moorei was isolated.
Ref. Sample type Patient Medical history Culture results Antimicrobial therapy Clinical
outcome
[13] Blood culture 43-year-old
woman
Cervix carcinoma Solobacterium moorei Cefuroxime/ Piperacillin/tazobactam Recovered
[3] Blood culture 67-year -old
man
Multiple myeloma Solobacterium moorei Cefepime Amikacin Vancomycin Recovered
[12] Blood culture 43-year-old
man
Lymphoma, kidney transplantation Solobacterium moorei Phenoxymethyl-penicillin/
Benzylpenicillin Metronidazole
Recovered
[12] Blood culture 64-year-old
woman
Colon cancer Solobacterium moorei Cefuroxime Metronidazole Recovered
[17] Blood culture 61-year-old
man
Diabetes mellitus, rectal cancer Solobacterium moorei
Streptococcus mitis
Cefuroxime Moxifloxacin/ Vancomycin
Meropenem
Died
[12] Blood culture 66-year-old
woman
Non-small cell lung carcinoma Solobacterium moorei
Eikenella corrodens
Meropenem/ Ciprofloxacin
Metronidazole
Recovered
[12] Blood culture 33-year-old
woman
IVDA Hepatitis B infection Solobacterium moorei
Actinomyces meyeri
Cefuroxime/ Benzylpenicillin
Metronidazole
Recovered
[12] Blood culture 77-year-old
man
Ischemic heart disease Prostate cancer Solobacterium moorei
Porphyromonas
uenonis
Benzylpenicillin/ Phenoxy-
methylpenicillin
Recovered
[18] Blood culture 70-year-old
man
HIV- positivity Solobacterium moorei
Campylobcater rectus
Amoxicillin/clavulanic acid Recovered
[4] Blood culture 37-year-old
man
Femoral vein thrombophlebitis with septic
pulmonary embolism
Solobacterium moorei
Fusobacterium
nucleatum
Bacteroides urealyticus
Penicillin Metronidazole Recovered
[5] Thigh abscess ND ND Solobacterium moorei
Actinomyces europeus
Enterococcus faecalis
Stenotrophomonas
maltophilia
Comamonas
testosterone
Corynebacterium sp.
Corynebacterium
urealyticum
Not reported Recovereda
[5] Abdominal wound
abscess
ND Perforated appendix Solobacterium moorei
Peptosterptococcus
micros
Slackia exigua
Bacteroides fragilis
Bilophila wadsworthia
Enterococcus avium
Eikenella corrodens
Escherichia coli
Not reported Recovereda
[5] Axilla furuncle ND ND Solobacterium moorei
Stphylococcus aureus
Propionibacterium sp.
Corynebacterium sp.
amycolatum
Not reported Recovereda
[5] Abdominal wound ND ND Solobacterium moorei
Prevotella nigrescens
Parvimonas micra
Streptococcus
constellatus
Fusobacterium
nucleatum
Actinomyces turicensis
Dialister pneumosintes
Bacteroides urealyticus
Pseudomonas
aeruginosa
Bacteroides fragilis
Bacteroides ovatus
Not reported Recovereda
[5] Perirectal abscess ND ND Solobacterium moorei
Actinomyces turicensis
Streptococcus
anginosus
Bacteroides sp.
Prevotella disiens
Megaspera sp.
Fusobacterium
nucleatum
Porphyromonas sp.
Not reported Recovereda
[5] Perirectal abscess ND Diabetes mellitus Solobacterium moorei
Parvimonas micra
Not reported Recovereda
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Table 2 (continued )
Ref. Sample type Patient Medical history Culture results Antimicrobial therapy Clinical
outcome
Actinomyces turicensis
Bacteroides fragilis
Fusobacterium equinum
Streptococcus
constellatus
Staphylococcus aureus
Escherichia coli
[5] Infected pilonidal
cyst
ND ND Solobacterium moorei
Parvimonas micra
Streptococcus
anginosus
Bilophila wadsworthia
Peptostreptococcus sp.
Not reported Recovereda
[5] Thigh abscess ND IVDA, heroin Solobacterium moorei
Streptococcus
anginosus
Parvimonas micra
Atopobium sp.
Streptococcus
constellatus
Not reported Recovereda
[5] Pilonidal abscess ND ND Solobacterium moorei
Parvimonas micra
Fusobacterium
gonidiaformans
Atopobium minutum
Slackia exigua
Prevotella intermedia
Tannerella forsythia
Prevotella stomatis
Bacteroides vulgatus
Actinomyces turicensis
Not reported Recovereda
ND: No data IVDA: intravenous drug abuse.
a Recovered after surgical intervention and routine antibiotic treatment.
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32 S. moorei strains were isolated and identified by the end of 2019.
Most of the S. moorei cases (six) were discovered in 2016; these
cases are presented in detail in this case report. During subcultur-
ing, the clinical isolates of S. moorei form small, grey, non-hemolytic
colonies with a 0.5e1 mm diameter on Schaedler blood agar after
being incubated for 48 h in a strict anaerobic environment (Fig. 1).
Because of their small colony size, S. moorei colonies are often
overlooked in mixed culture if the sample is not carefully spread on
the original plate. In previous studies that primarily usedmolecular
methods, S. moorei was mentioned as a member of a complex
microbiome associated with different infections of the oral cavity
such as periimplantitis [6], root canal [7], periradicular lesions [8],
dentoalveolar abscess [9], apical endodontic abscess [10], and re-
fractory periodontitis [11] together with other anaerobic and aer-
obic bacteria. Furthermore, it has been suggested that S. moorei,
which produces volatile sulfur compounds (e.g., hydrogen sulfide
and methyl mercaptan) and organic acids (e.g., amines such as
cadaverine, etc.), together with other oral anaerobic bacteria, may
play role in the formation of halitosis [2,16].
Altogether, 19 clinical cases have been described in detail since
2006 in which S. moorei was isolated alone or in mixed culture
(Table 2). The reported cases of S. moorei bacteraemia were mostly
associated with cancers: cervix carcinoma with acute proctitis [13],
kidney transplantation with lymphoma, lung carcinoma, colon
cancer, prostate cancer with pneumonia and ischaemic heart dis-
ease [12], andmultiple myeloma [3]. Pedersen et al. reported on the
isolation of S. moorei from the blood culture of a patient who used
intravenous drugs and was infected with hepatitis B [12]. Martin
et al. reported on S. moorei bacteraemia in a case of femoral vein
thrombosis with septic pulmonary embolism [4]. In four casereports, S. moorei was isolated from blood culture as the only
pathogen, but in some patients, in addition to S. moorei, other
aerobic or anaerobic bacteria were present in the blood sample
(Table 2). Our patient with S. moorei bacteraemia also had several
debilitating conditions such as cancer and pyothorax. He died
without any antibiotic therapy to treat the sepsis, despite the fact
that the blood culture isolate was fully susceptible to all tested
antibiotics (Table 1).
Zhen et al. [5] described nine cases of polymicrobial infections
that had no clear connection with the oral cavity. These cases were
obtained from wound infections, including abdominal abscesses,
infected pilonidal cyst and abscess, axilla furuncle, perirectal ab-
scesses, and abdominal wound infections, in which S. moorei was
isolated with higher or lower colony counts or was detected by 16S
rRNA gene sequence analysis [5] (Table 2). The antibiotic suscep-
tibility was also determined in a study on six S. moorei isolates. All
isolates were fully susceptible to antibiotics usually used for the
empirical treatment of mixed infections involving anaerobic bac-
teria [5]. The five additional polymicrobial cases presented in this
report in which S. moorei was isolated, together with one to five
other different types of bacteria, were also associated with cancers
(e.g., colorectal, facial, skin, laryngeal, lung) and immunosuppres-
sive status (e.g., diabetes mellitus, chemotherapy, radiotherapy). In
three patients, the infection had a direct connection with the oral
cavity (including a middle ear infection, mandibular abscess, and
wound infection after total laryngectomy) (Table 1). Except our fifth
case, in which S. moorei and A. randingae were isolated only from
the enrichment broth and were not considered real pathogens, the
empirically initiated antibiotic therapy covered the mixed flora of
the infection (Table 1). In the majority of published bloodstream
infections involving S. moorei, the patients recovered, but in our
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gression of the infection due to the underlining diseases was rapid
with [17] or without antibiotic therapy (our first case), and the
patient died.
The introduction of the MALDI-TOF MS method for the identi-
fication of slow-growing and difficult-to-identify culturable bac-
teria or fungi broadened our view about the possible pathogens of
mixed infections. Conversely, the more time-consuming PCR-based
method to identify culturable or non-culturable members of mixed
infections has also been used by several authors [6e9]. The MALDI
Biotyper system with various database developments focuses on
different, difficult-to-identify species including anaerobic bacteria
present in the normal flora or in different infections [19,20]. Ac-
cording to our laboratory database, since 2013, we have identified
32 S. moorei strains on the species level with log (score) values of
2.000, including the isolates of the presented cases using the
actual database developments of the MALDI Biotyper. Liu W-J. et al.
reported that they could not identify their S. moorei isolate with
commercial biochemical tests or the MALDI-TOF MS method, but
they could identify it with 16S rRNA gene sequencing [17]. There is
no information on the version of the software applied in that study.
Several publications mention the isolation of S. moorei from
mixed infections associated with the oral cavity or suggest the
possible translocation of it from the gastrointestinal tract. However,
the clinical significance of this rarely identified gram-positive
anaerobic bacterium remains largely unknown because it is fully
susceptible to antibiotics regularly used in mixed infections
involving aerobic and anaerobic bacteria. Only one patient died due
to sepsis when S. moorei was the causative agent with the usage of
targeted antibiotic therapy (Table 2). All other bacteraemia patients
in whom S. moorei was present in at least one anaerobic blood
culture bottle alone or together with some other anaerobic bacteria
survived the infection because of appropriate antibiotic therapy.
The role of S. moorei in other mixed infections with abscess for-
mation in different parts of the body, occasionally involving up to
10 different and mostly anaerobic bacteria, is very difficult to judge
[5]. According to the published data and our experience, wound
infections involving S. moorei resolved after routine surgical man-
agement and various anti-anaerobic antibiotic regimens.
S. moorei, which is part of the human microbiota, seems to be a
less virulent germ; however, in infectious processes that are con-
nected with several debilitating predisposing factors, the patient
may even develop bacteraemia involving S. moorei.Our case reports
demonstrate the value of the carefully usedMALDI-TOFMSmethod
for the identification of anaerobic bacteria including S. moorei, the
pathogenic role of which should be carefully evaluated in every
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